Castration-resistant Prostate Cancer
📧 Sign up to get email alerts when something new happens for Castration-resistant Prostate Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-09-05Clinical Trial Update: Observational Study for the Evaluation of Long-term Safety of Radium-223 Used for the Treatment of Metastatic Castration Resistant Prostate Cancer
An observational study evaluating the long-term safety of Radium-223 dichloride (Xofigo) for metastatic castration-resistant prostate cancer…
-
CLINICAL_TRIALS trial_result · 2025-08-29Clinical Trial Update: 64Cu-SAR-BBN and 67CU SAR-BBN for Identification and Treatment of Gastrin Releasing Peptide Receptor (GRPR)-Expressing Metastatic Castrate Resistant Prostate Cancer in Patients Who Are Ineligible for Therapy With 177Lu-PSMA-617 (COMBAT) [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating 64Cu-SAR-BBN and 67Cu-SAR-BBN for identification and treatment of metastatic castration-resistant prosta…
-
CLINICAL_TRIALS trial_result · 2025-08-28Clinical Trial Update: Re-treatment 225Ac-J591 for mCRPC [EARLY_Phase 1]
An early-phase (Phase 1) trial evaluating re-treatment with Actinium-225 labeled J591 for metastatic castration-resistant prostate cancer ha…
-
CLINICAL_TRIALS trial_result · 2025-08-21Clinical Trial Update: Darolutamide + Consolidation Radiotherapy in Advanced Prostate Cancer Detected by PSMA [Phase 2]
Phase 2 clinical trial evaluating darolutamide with consolidation radiotherapy in advanced PSMA-detected prostate cancer; the study is curre…
-
CLINICAL_TRIALS trial_result · 2025-08-20Clinical Trial Update: Carboplatin or Olaparib for BRcA Deficient Prostate Cancer [Phase 2]
Phase 2 clinical trial evaluating carboplatin or olaparib in BRCA-deficient metastatic castration-resistant prostate cancer; the study is cu…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-08-17Clinical Trial Update: Study of Relugolix in Men With Metastatic Castration-Sensitive Prostate Cancer or Non-Metastatic or Metastatic Castration-Resistant Prostate Cancer [Phase 1]
This ClinicalTrials.gov update reports the completion of a Phase 1 study evaluating relugolix in men with metastatic castration-sensitive an…
-
CLINICAL_TRIALS trial_result · 2025-08-11Clinical Trial Update: A Phase I/IIa Trial of HMBD-001 in Advanced HER3 Positive Solid Tumours [Phase 1, Phase 2]
Cancer Research UK reported an ongoing Phase 1/2a trial of HMBD-001 in HER3-positive solid tumors; the study is currently Active Not Recruit…
-
CLINICAL_TRIALS trial_result · 2025-08-08Clinical Trial Update: Study to Evaluate CCS1477 in Advanced Tumours [Phase 1, Phase 2]
A Phase 1/2 study of CCS1477 has completed, evaluating it in metastatic castration-resistant prostate cancer and metastatic breast cancer, w…
-
CLINICAL_TRIALS trial_result · 2025-08-07Clinical Trial Update: Phase 1, First-in-human, Dose-finding and Expansion Study to Evaluate XmAb®808 in Combination With Pembrolizumab in Advanced Solid Tumors [Phase 1]
Phase 1, first-in-human dose-finding and expansion study of XmAb808 in combination with pembrolizumab in advanced solid tumors; the trial ha…
-
CLINICAL_TRIALS trial_result · 2025-08-01Clinical Trial Update: Trial of LAVA-1207 in Patients With Therapy Refractory Metastatic Castration Resistant Prostate Cancer (mCRPC) Resistant Prostate Cancer [Phase 1]
A Phase 1 study of LAVA-1207 in patients with therapy-refractory metastatic castration-resistant prostate cancer has been terminated.
-
CLINICAL_TRIALS trial_result · 2025-07-31Clinical Trial Update: MGC018 With or Without MGA012 in Advanced Solid Tumors [Phase 1, Phase 2]
This clinical trial update reports results from the combination of MGC018 with or without MGA012 (pembrolizumab) in advanced solid tumors. T…
-
CLINICAL_TRIALS trial_result · 2025-07-25Clinical Trial Update: Trial of ARV-110 and Abiraterone in Patients With Metastatic Castration Resistant Prostate Cancer (mCRPC) [Phase 1]
Phase 1 trial evaluating ARV-110 in combination with Abiraterone for Metastatic Castration-Resistant Prostate Cancer has completed.
-
CLINICAL_TRIALS trial_result · 2025-07-22Clinical Trial Update: Adenosine Receptor Antagonist Combination Therapy for Metastatic Castrate Resistant Prostate Cancer [Phase 1, Phase 2]
This clinical trial update reports the completion of a Phase 1/2 study evaluating an adenosine receptor antagonist in combination therapy fo…
-
CLINICAL_TRIALS trial_result · 2025-07-17Clinical Trial Update: XmAb®20717 (Vudalimab) Alone or in Combination With Chemotherapy or Targeted Therapy in Patients With Metastatic Castration-Resistant Prostate Cancer [Phase 2]
Clinical trial update noting the completion of a Phase 2 study of XmAb20717 (Vudalimab), as monotherapy or in combination with chemotherapy …
-
CLINICAL_TRIALS trial_result · 2025-07-17Clinical Trial Update: Gallium Ga 68-DOTATATE PET/CT in Diagnosing Patients With Metastatic Castration Resistant Prostate Cancer [Phase 2]
Phase 2 trial evaluating Ga-68 DOTATATE PET/CT for diagnosing metastatic castration-resistant prostate cancer has completed, with results po…
-
CLINICAL_TRIALS trial_result · 2025-07-11Clinical Trial Update: INCB106385 Alone or in Combination With Immunotherapy in Advanced Solid Tumors [Phase 1]
A Phase 1 trial of INCB106385, alone or with immunotherapy, in advanced solid tumors has completed. The study includes multiple indications …
-
CLINICAL_TRIALS trial_result · 2025-07-10Clinical Trial Update: Drug Use Investigation of Xofigo, Castration Resistant Prostate Cancer With Bone Metastases
A completed clinical trial investigating the use of Xofigo (radium-223 dichloride) in metastatic castration-resistant prostate cancer with b…
-
CLINICAL_TRIALS trial_result · 2025-07-09Clinical Trial Update: 68Ga-PSMA-11 PET/CT Screening Prior to 177Lu-PSMA-617 Therapy for Patients With Metastatic Castrate Resistant Prostate Cancer [Phase 3]
Phase 3 trial evaluating 68Ga-PSMA-11 PET/CT screening before Lu-177-PSMA-617 therapy in metastatic castration-resistant prostate cancer has…
-
CLINICAL_TRIALS trial_result · 2025-06-29Clinical Trial Update: Study on Olaparib Plus Abiraterone as First-line Therapy in Men With Metastatic Castration-resistant Prostate Cancer (China Cohort) [Phase 3]
A Phase 3 China-cohort trial investigates combining olaparib with abiraterone as first-line therapy for men with metastatic castration-resis…
-
CLINICAL_TRIALS trial_result · 2025-06-24Clinical Trial Update: A Study of SHR3680 in Combination With SHR3162 in the Treatment of mCRPC [Phase 2]
Phase 2 study of SHR3680 in combination with SHR3162 for metastatic castration-resistant prostate cancer has been terminated. The trial (NCT…
-
CLINICAL_TRIALS trial_result · 2025-06-17Clinical Trial Update: A Study of AMG 340 in Subjects With Metastatic Castrate-Resistant Prostate Carcinoma [Phase 1]
Phase 1 study of AMG 340 in metastatic castration-resistant prostate cancer was terminated. Results were posted on 2025-06-17.
-
CLINICAL_TRIALS trial_result · 2025-06-12Clinical Trial Update: Docetaxel, Carboplatin, and Rucaparib Camsylate in Treating Patients With Metastatic Castration Resistant Prostate Cancer With Homologous Recombination DNA Repair Deficiency [Phase 2]
A Phase 2 trial evaluating a combination of docetaxel, carboplatin, and rucaparib camsylate in metastatic castration-resistant prostate canc…
-
CLINICAL_TRIALS trial_result · 2025-06-10Clinical Trial Update: Pembrolizumab With Combination Chemotherapy in Treating Participants With Locally Advanced or Metastatic Small Cell/Neuroendocrine Cancers of Urothelium or Prostate [Phase 1]
Phase 1 trial evaluating pembrolizumab with chemotherapy for locally advanced or metastatic small cell and neuroendocrine cancers of the uro…
-
CLINICAL_TRIALS trial_result · 2025-06-10Clinical Trial Update: A Study of BMS-986218 or BMS-986218 Plus Nivolumab in Combination With Docetaxel in Participants With Metastatic Castration-resistant Prostate Cancer [Phase 2]
A Phase 2 study of BMS-986218 alone or with nivolumab plus docetaxel in metastatic castration-resistant prostate cancer has been terminated.…
-
CLINICAL_TRIALS trial_result · 2025-06-08Clinical Trial Update: Phase I/II Study of Immunotherapy Combination BN-Brachyury Vaccine, M7824, N-803 and Epacadostat (QuEST1) [Phase 1, Phase 2]
This Phase I/II trial of BN-Brachyury Vaccine, M7824, N-803, and Epacadostat in metastatic castration-resistant prostate cancer has complete…